Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF) | Patent Number 11197869

US 11197869 B2
Application Number17233302
Publication NumberUS 20210252017 A1
Pendency8 months, 2 days
Filled DateApr 16, 2021
Priority DateMar 5, 2019
Publication DateAug 19, 2021
Expiration DateMar 4, 2039
Inventor/ApplicantsPatrizia Ferrari
Mara Ferrandi
Paolo Barassi
Giuseppe Bianchi
ExaminesROZOF, TIMOTHY R
Art Unit1625
Technology Center1600
Assignments
Windtree Therapeutics Inc.
Current
Windtree Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.